King Pharmaceuticals KG North America — Gross premiums written
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PremiumsWrittenGross.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's north america — gross premiums written.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's north america — gross premiums written?
- King Pharmaceuticals (KG) reported north america — gross premiums written of -$48.75K in Q4 2025.
- What does north america — gross premiums written mean?
- This metric represents the total amount of premiums on insurance policies written by the North American segment before accounting for reinsurance cessions. It serves as a primary indicator of the segment's top-line growth and market penetration within the region. Monitoring this figure helps investors assess the scale of business origination and the company's competitive reach in the North American insurance market.